Römer, Tristan
Vokuhl, Christian
Staatz, Gundula
Mottaghy, Felix M.
Christiansen, Hans
Eble, Michael J.
Timmermann, Beate
Klussmann, Jens Peter
Elbracht, Miriam
Calaminus, Gabriele
Zimmermann, Martin
Brümmendorf, Tim H.
Feuchtinger, Tobias
Kerp, Helena
Kontny, Udo
Funding for this research was provided by:
RWTH Aachen University
Article History
Accepted: 18 November 2023
First Online: 12 January 2024
Declarations
:
: T. Römer, C. Vokuhl, G. Staatz, F.M. Mottaghy, H. Christiansen, M.J. Eble, B. Timmermann, J.P. Klussmann, M. Elbracht, G. Calaminus, M. Zimmermann, T.H. Brümmendorf, T. Feuchtinger, H. Kerp and U. Kontny declare that they have no competing interests.
: This study was first approved on August 8, 2022, by the German national competent authority Paul Ehrlich Institute (PEI) and the Ethics Committee under the EU Clinical Trials Regulation 536/2014 via the Clinical Trials Information System (CTIS). Conduct of the trial including patient information and consent forms were authorized by the European Medicines Agency (No. 2022-500676-59-00). All studies mentioned were in accordance with the ethical standards indicated in each case. Consent for publication of data is integrated in the general consent form, which is handled out initially to the patients and/or parent/legal guardians.